Axogen (AXGN) is the leading company focused specifically on the science, development and commercialization of technologies for peripheral nerve regeneration and repair. We are passionate about helping to restore peripheral nerve function and quality of life to patients with physical damage or discontinuity to peripheral nerves by providing innovative, clinically proven and economically effective repair solutions for surgeons and health care providers. Mission:?Every day, people suffer traumatic injuries or undergo surgical procedures that impact the function of their peripheral nerves. Physical damage to a peripheral nerve, or the inability to properly reconnect peripheral nerves, can result in the loss of muscle or organ function, the loss of sensory feeling, or the initiation of pain. Axogen?s comprehensive portfolio of products focuses on helping patients touch, run, feel, kiss, smile and hug?some of the many things healthy peripheral nerves allow us to do.
201 to 500 Employees
TypeCompany - Public (AXGN)
Revenue$100 to $500 million (USD)
IndustryBiotech & Pharmaceuticals
CompetitorsUnknown
Founded1995